Home  >  TopNews
Eppen_SpinPro_Apr26
you can get e-magazine links on WhatsApp. Click here
TopNews
  MDC seeks written reply from Biological E on exemption of Pneubevax 14 from DPCO pricing,   April 17, 2026
  Maharashtra FDA proposes Rs. 500 crore plan to strengthen drug regulatory system & lab infra in the state,   April 15, 2026
  DCC recommends formation of sub-committees on various proposals for amendment of D&C Rules,   April 15, 2026
  Panel asks DoP to ensure budget allocations for bulk drug parks to be in tandem with implementation capacity,   April 14, 2026
  Maharashtra FDA recruitment drive gains momentum as process for 154 DIs’ appointment advances,   April 14, 2026
  DCC forms sub-committee to look into feasibility of public disclosure of RBI details,   April 13, 2026
  DCC recommends shifting of four drugs from Schedule H to H1 to bring them under tighter regulation,   April 13, 2026
  DoP to examine necessity of a procurement manual for public procurement of medicines,   April 11, 2026
  Panel asks DoP to boost domestic manufacturing of all products under PLI scheme for bulk drugs,   April 10, 2026
  DTAB asks health ministry to scrap draft notification prohibiting ads of Schedule G drugs,   April 10, 2026
  DCC approves proposal to create real-time digital portal to track drugs under NDPS Act,   April 09, 2026
  DCOIWA unveils blueprint to eradicate spurious drugs, field staff to act as 'first line of surveillance',   April 09, 2026
  DoP again tweaks RPTUAS guidelines to liberalise modalities of implementation,   April 08, 2026
  DTAB not to pursue proposal to mandate free medicine from pharma cos as part of CSR,   April 08, 2026
  DTAB recommends amendment of PSUR reporting period norms under NDCT Rules,   April 07, 2026
  DCC recommends amendment of rules to mandate installation of CCTV cameras at medical stores,   April 07, 2026
  Parliamentary Panel asks DoP to address issues in RPTUAS for fund utilisation,   April 06, 2026
  DTAB recommends revision of microbial contamination limits in Schedule M,   April 06, 2026
  NPPA exempts Intas Pharma's patented antipsychotic formulation from DPCO for five years,   April 01, 2026
  No allocation for SSDRS in 2026-27; Panel recommends Rs. 490 crore for new version,   April 01, 2026

  • Results Found: 6623
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 332
 Back
 
Propak_Asia_2026
echemi_logo26
API_China2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram